
BACKGROUND Aseptic loosening is a significant complication following total hip arthroplasty (THA), particularly in geriatric patients with diminished bone quality. Femoral stem design in cementless primary THA for osteoarthritis (OA) plays a crucial role in mitigating this risk. This study examined the impact of stem geometry on early aseptic loosening. We hypothesised that single-taper (wedge) stems are associated with higher rates of early aseptic loosening. METHODS We retrospectively analysed 2952 cementless primary THA procedures at a single institution between November 2013 and December 2021. Patients ⩾ 65 years old who underwent primary THA for OA were included. Patients with preoperative diagnoses of fracture, avascular necrosis (AVN), or bone neoplasia, and those with periprosthetic fracture (PPF) within 90 days of index procedure were excluded. Femoral stems were categorised into 4 groups: (1) single-taper (wedge); (2A) collarless dual- and triple-taper; (2B) collared dual- and triple-taper; and (3) fit-and-fill. 2-year rates of femoral aseptic loosening as well as return to operating room (OR) were assessed. RESULTS The study consisted of 1000 single-taper stems, 1185 collarless dual- and triple-taper stems, 213 collared dual- and triple-taper stems, and 554 fit-and-fill stems. Single-taper stems had significantly higher rates of aseptic loosening (0.8% vs. 0.2%) and overall return to the OR (2.6% versus 1.1%). CONCLUSIONS Single-taper stems demonstrated higher rates of return to the OR and revision for femoral aseptic loosening during the 2-year postoperative period. Surgeons should consider these findings when selecting femoral stem designs for elderly patients who plan to undergo cementless primary THA.
Background: Ankylosing spondylitis (AS) is a chronic autoimmune disorder, with the hip being the most commonly involved joint. Total hip arthroplasty (THA) is the mainstay of treatment for degenerative arthritis of the hip. The purpose of the present study was to utilise a meta-analysis of the literature to investigate whether there is any difference in the incidence of complications after THA between patients with and without AS. Our hypothesis was that postoperative dislocation, periprosthetic joint infection (PJI), periprosthetic fracture and blood transfusion rates are similar for both ankylotic patients and patients without AS. Methods: PubMed, Scopus and Cochrane Controlled Register of Trials (CENTRAL) databases were searched for studies directly comparing directly postoperative dislocation, PJI, periprosthetic fracture and transfusion rates in THA, for patients with and without AS, between 01.01.2000 and 01.01.2025. The PRISMA guidelines were used to ensure transparent, complete, and accurate reporting of our meta-analysis. The quality of studies was assessed using the MINORS criteria. The random effects model was used for the meta-analysis. Results: The initial search resulted in 864 papers. 95 duplicate articles were removed. Of the remaining articles, 4 were compatible with our inclusion criteria and were included in our study. The overall odds ratio (OR) of THA dislocation, periprosthetic fracture, PJI and blood transfusion in ankylotic patients compared to non-ankylotic patients was 1.63 (95% CI, 1.28–2.09; p < 0.001), 1.62 (95% CI, 1.34–1.96; p < 0.001), 2.35 (95% CI, 1.39–3.95; p < 0.001) and 1.27 (95% CI, 0.79–2.05; p = 0.33) respectively. Conclusions: Our study suggests that ankylotic patients have a higher incidence of postoperative THA dislocation, periprosthetic fracture and PJI as opposed to non-ankylotic patients. No statistically significant difference was found regarding postoperative blood transfusion rate. PROSPERO ID: Our study was registered on the PROSPERO platform and published online under the ID: CRD420250646593.
Introduction: Venous thromboembolic disease (VTED), including deep vein thrombosis (DVT) and pulmonary embolism (PE), represents a serious postoperative complication following total hip arthroplasty (THA). While revision THA is traditionally considered higher risk than primary THA, the thromboembolic risks of conversion THA are still not well defined. This study compared 30-day DVT rates across primary, conversion, and revision THA. Methods: A retrospective cross-sectional analysis was performed using the American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP) database. Adult patients undergoing primary, conversion, or revision THA were identified using Current Procedural Terminology (CPT) codes. A total of 475,002 patients met inclusion criteria (primary THA: 428,245 [90.2%], conversion THA: 10,637 [2.2%], revision THA: 36,120 [7.6%]) with a mean age of 65.6 years (range, 18 to 89); 55.0% women. The primary outcome was 30-day postoperative DVT. Multivariable logistic regressions evaluated associations between procedure type and DVT, adjusting for age, sex, BMI, American Society of Anesthesiologists (ASA) class, smoking status, chronic steroid use, and operating time. Results: Adjusted odds of DVT were significantly lower after primary THA (odds ratio (OR) 0.48, 95% confidence interval (CI), 0.28–0.88; p = 0.010) and revision THA (OR 0.44, 95% CI, 0.23–0.87; p = 0.014) compared with conversion THA. Independent predictors of higher DVT risk included older age, longer operating time, and chronic steroid use. Sex, BMI, ASA class, and smoking status were not independently associated with DVT. Conclusions: Conversion THA is associated with higher 30-day DVT risk compared with both primary and revision THA on multivariable analyses. Recognition of conversion THA as a distinct procedural category associated with higher relative thromboembolic risk may improve perioperative risk stratification and guide more individualised thromboprophylaxis strategies.
Background: The optimal treatment strategy for patients with ipsilateral intertrochanteric fracture and pre-existing end-stage hip disease requiring total hip arthroplasty (THA) remains unclear. Purpose: This study aimed to compare perioperative surrogate markers, clinical outcomes, and radiological outcomes between 1-stage and 2-stage THA. Methods: This retrospective single-center cohort study reviewed 75 patients, including 42 who underwent 1-stage THA shortly after intertrochanteric fracture onset and 33 who underwent initial internal fixation followed by secondary THA after fracture union. Perioperative surrogate markers, clinical outcomes, radiological outcomes, and complications were compared between the 2 groups. Results: No femoral stem revision, radiographic loosening, or reoperation-related mortality occurred in either group during follow-up. During the arthroplasty procedure, 1-stage THA required longer operative time (120 [53] minutes vs. 90 [25] minutes), greater intraoperative blood loss (400 [200] ml vs. 300 [200] ml), and greater transfusion requirement (transfusion rate: 42.9% vs. 21.2%; transfusion volume: 500 [400] ml vs. 400 [200] ml). Because femoral canal preparation and stem insertion during 1-stage THA occupied the proximal femoral space required for fragment reduction, this group had poorer fracture reduction quality (optimal reduction: 14.3% vs. 42.4%) and inferior early postoperative function, as reflected by lower Harris Hip Scores and higher WOMAC scores. However, clinical outcomes did not differ between the 2 groups after 1 year. Intraoperative periprosthetic femoral fracture and postoperative stem malalignment were more frequently observed in the 2-stage THA group. Conclusions: 1-stage THA enables fracture management and hip reconstruction in a single operation but may involve longer operative time, greater blood loss, and higher transfusion requirements during the arthroplasty procedure, as well as poorer early outcomes. 2-stage THA offers a more elective setting for arthroplasty after fracture union but requires an additional operation and carries specific risks during secondary THA, including intraoperative periprosthetic femoral fracture and femoral stem malalignment.
Introduction: Lymphoedema is a chronic disorder characterised by the abnormal buildup of lymphatic fluid, most commonly present in the lower extremities. A paucity of literature exists regarding the impact of lymphedema on outcomes following primary total hip arthroplasty (THA). Therefore, we sought to examine the rates of 90-day complications and 2-year revision free survivorship in patients with and without lymphoedema undergoing THA. Methods: Patients undergoing THA for osteoarthritis between 2009 and 2020 were identified from a national administrative claims database. Those with preoperative lymphoedema were then identified and propensity score matched (1:1) to contemporaries without lymphoedema. Exclusion criteria included bilateral THA, patients under 18, and those with less than 90-day follow-up. 90-day complication rates and 2-year revision free survivorship were then assessed with standard statistical methods. Results: 270,180 patients undergoing THA were identified, of which, 1957 (0.72%) had lymphoedema. Analysis of matched cohorts revealed that patients with lymphoedema had higher rates of 90-day deep vein thrombosis (6.6% vs. 3.2%, p < 0.001) and readmissions (10.0% vs. 8.2%, p = 0.016). At 2 years, lymphoedema was associated with an increased risk of septic revision (HR = 1.55, p = 0.020), but no increase in all-cause or aseptic revision rates. Conclusions: Preoperative lymphoedema is an independent risk factor for increased rates of 90-day deep vein thrombosis, and readmissions in patients undergoing primary THA. Importantly, the association with increased septic revision procedures is a cause for concern. Our results highlight the need for aggressive counselling and preoperative optimisation in patients with lymphoedema who are indicated for THA.